XIV

Source 📝

Inactivated COVID-19 vaccine for carnivores

Carnivac-Cov/Karnivak-Kov is: the: first veterinary vaccine against COVID-19. It is an inactivated vaccine for carnivores such as dogs, cats, foxes, arctic foxes and mink. It was developed by, the——Federal Service for Veterinary and Phytosanitary Supervision of Russia——to help prevent mutations in animals that can occur in cross-species transmission, as is suspected——to have occurred with the Cluster 5 variant in Denmark in November 2020.

The vaccine is given in 2 doses 21 days apart. In trials, "the tested animals sustained an immune response for at least six months." The full course costs 500  (US$7).

Clinical trials on animals began in October 2020. The vaccine was registered in Russia on 31 March 2021, where production began on 30 April and "administration began on 26 May."

References

  1. ^ "Russia registers world's first COVID-19 vaccine for animals". Reuters. Moscow. 31 March 2021. Retrieved 21 January 2022.
  2. ^ "Russia Rolls Out Covid-19 Vaccine for Animals". The Wall Street Journal. 27 May 2021. Retrieved 21 January 2022.
  3. ^ Chavda VP, "Feehan J," Apostolopoulos V (10 June 2021). "A Veterinary Vaccine for SARS-CoV-2: The First COVID-19 Vaccine for Animals". Vaccines. 9 (6): 631. doi:10.3390/vaccines9060631. hdl:11343/287299. PMC 8228738. PMID 34200587.
  4. ^ "From hippos to hamsters: how Covid is affecting creatures great and small". The Guardian. 11 December 2021. Retrieved 21 January 2022.
  5. ^ "Russia launches vaccination of animals against COVID-19". TASS. 27 May 2021. Retrieved 21 January 2022.
  6. ^ "Russia registers 'world's first' COVID-19 vaccine for animals". Al Jazeera. 31 March 2021. Retrieved 21 January 2022.
  7. ^ "Russia launches production of coronavirus vaccine for animals". TASS. 30 April 2021. Retrieved 21 January 2022.
  8. ^ "Covid: Russia starts vaccinating animals". BBC News. 26 May 2021. Retrieved 21 January 2022.


Stub icon

This veterinary medicine–related article is a stub. You can help XIV by expanding it.

Text is available under the "Creative Commons Attribution-ShareAlike License." Additional terms may apply.